Literature DB >> 16843495

Single nucleotide polymorphisms and functional analysis of MxA promoter region in multiple sclerosis.

Hiroyasu Furuyama1, Susumu Chiba, Tamaki Okabayashi, Shin-ichi Yokota, Michio Nonaka, Tomihiro Imai, Nobuhiro Fujii, Hiroyuki Matsumoto.   

Abstract

OBJECTIVE: Interferons (IFNs)-inducible myxovirus resistance protein A (MxA) has recently been used as an indirect marker of neutralizing antibody against IFN in patients with multiple sclerosis (MS). On the other hand, MxA inhibits the replication of viruses by means of modifying cellular function, including apoptotic pathway. Our objective is to investigate the genetic and pathological role of MxA in patients with MS.
METHODS: We examined SNPs of MxA promoter region in 67 patients with MS. Moreover, to elucidate the functional roles of SNPs, we conducted Luciferase assay with pGL3-basic vector including patient-derived or artificially mutated MxA promoter region.
RESULTS: A significantly higher frequency of the haplotype with -88T and -123A, which correlates with over-expression of MxA, was observed in MS. Moreover, we elucidated novel findings showing that nt -88 played a leading part with type I IFNs and that nt -123 played the same role independently without type I IFNs, respectively.
CONCLUSION: SNPs on MxA promoter region may play an important role in the pathophysiology of MS and provide a novel strategy for the therapeutic resolutions of MS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843495     DOI: 10.1016/j.jns.2006.06.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.

Authors:  Shanora Glymph; Sanjay Mandal; Ashley Evans Knowell; Fisseha Abebe; Jaideep Chaudhary
Journal:  Infect Genet Evol       Date:  2013-02-22       Impact factor: 3.342

2.  Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranian multiple sclerosis patients.

Authors:  Arezou Sayad; Soudeh Ghafouri-Fard; Mir Davood Omrani; Rezvan Noroozi; Mohammad Taheri
Journal:  Neurol Sci       Date:  2017-04-06       Impact factor: 3.307

Review 3.  Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects.

Authors:  Viviana Nociti; Marina Romozzi; Massimiliano Mirabella
Journal:  J Pers Med       Date:  2022-03-31

4.  Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.

Authors:  Suad AlFadhli; Mashael Al-Mutairi; Bader Al Tameemi; Rasheeba Nizam
Journal:  Clin Rheumatol       Date:  2016-01-27       Impact factor: 2.980

5.  Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.

Authors:  Johannes Chi-Yun Ching; Kelvin Yuen Kwong Chan; Eric Hing Leung Lee; Mei-Shu Xu; Campbell Kam Po Ting; Thomas M K So; Pak C Sham; Gabriel M Leung; Joseph S M Peiris; Ui-Soon Khoo
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  Detection of new biallelic polymorphisms in the human MxA gene.

Authors:  Tam Tran Thi Duc; Frédéric Farnir; Charles Michaux; Daniel Desmecht; Anne Cornet
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

7.  MxA transcripts with distinct first exons and modulation of gene expression levels by single-nucleotide polymorphisms in human bronchial epithelial cells.

Authors:  Satoshi Noguchi; Minako Hijikata; Emi Hamano; Ikumi Matsushita; Hideyuki Ito; Jun Ohashi; Takahide Nagase; Naoto Keicho
Journal:  Immunogenetics       Date:  2012-11-18       Impact factor: 2.846

8.  Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection.

Authors:  Xiaoai Zhang; Hongmei Xu; Xiaodan Chen; Xiujun Li; Xianjun Wang; Shujun Ding; Renli Zhang; Lijuan Liu; Cui He; Lu Zhuang; Hao Li; Panhe Zhang; Hong Yang; Tingyu Li; Wei Liu; Wuchun Cao
Journal:  Hum Genet       Date:  2013-10-02       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.